Correlation Between Anthropometric Measurements And Balance IN Children With Cerebral Palsy

November 18, 2021 updated by: Ahmed Ibrahim Ali Ibrahim, Cairo University
The purpose of the current study is to evaluate the correlation between anthropometric measurement (weight, height and BMI) and balance in children with cerebral palsy.

Study Overview

Detailed Description

  • The European Society for Clinical Nutrition and Metabolism has pointed out that under-nutrition can led to change in body composition (e.g. depletion of body fat mass) and diminished function and outcome.
  • The prevalence of under-nutrition in children with CP varies from 3.9 per cent to 71 percent mainly depending on the method of assessment, the severity of motor involvement and feeding problems.
  • Studies indicate that children and adults with both mild and severe forms of CP have postural impairments. Dysfunctional posture control interferes with the activities of daily life .
  • Children with CP may have impaired muscle tone and abnormal postural control, both of which affect functional balance capacity.
  • There were associations between excess body weight and values below normal in some balance conditions, indicating that the anthropometric indicators interfered in the children's postural balance.

There were associations between excess body weight and values below normal in some balance conditions, indicating that the anthropometric indicators interfered in the children's postural balance.

Knowledge of anthropometric measurements and whether they affect balance in children with CP will help clinicians to develop treatment programs which in turn will improve the overall balance and functional abilities of children with CP.

  • Childeren age will be ranged from 8-12 years and on level Ⅰ and Ⅱ on Growth Motor Function Classification System
  • Weight would be obtained on a digital scale (UNISCALE )
  • Standing height was measured using a stadiometer with a fixed vertical backboard and an adjustable head piece.
  • CDC 2000 charts will be used to measure BMI
  • The Biodex balance system will be used for the assessment of static and dynamic balance of all children

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt
        • Recruiting
        • Cairo University
        • Contact:
          • Walaa Abd El-Nabie
          • Phone Number: 201115606185

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 12 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Their age will be ranged from 8 to 12 years.
  2. The degree of their spasticity will be ranged from 1 to 2 according to Modified Ashworth' Scale.
  3. They will be on level Ⅰ and Ⅱ on Growth Motor Function Classification System (GMFCS).
  4. They will be able to stand without the use of an assistive device
  5. Children can follow instructions and understand given orders.

Exclusion Criteria:

  1. Severe visual or hearing impairment.
  2. Fixed deformities or surgical interventions in the lower extremities.
  3. Botulinum toxin injections in the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: hemiplegic cp
it will be classified into two subgroups according to body mass index to underweight and healthy weight .
The Biodex balance system will be used for the assessment of static and dynamic balance of all children in the current study.
Experimental: diplegic cp
it will be classified into two subgroups according to body mass index to underweight and healthy weight .
The Biodex balance system will be used for the assessment of static and dynamic balance of all children in the current study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Is there a correlation between anthropometric measurements and balance in children with cerebral palsy?
Time Frame: 6 months
The purpose of the current study is to evaluate the correlation between anthropometric measurement (weight, height and BMI) and balance in children with cerebral palsy.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Gehan El meniawy, Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 23, 2021

Primary Completion (Anticipated)

February 28, 2022

Study Completion (Anticipated)

February 28, 2022

Study Registration Dates

First Submitted

November 18, 2021

First Submitted That Met QC Criteria

November 18, 2021

First Posted (Actual)

December 1, 2021

Study Record Updates

Last Update Posted (Actual)

December 1, 2021

Last Update Submitted That Met QC Criteria

November 18, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study Protocol and Statistical Analysis Plan

IPD Sharing Time Frame

starting 6 months after publication

IPD Sharing Access Criteria

IPD will be shared with researchers

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anthropometric Measurements&Balance IN CP Children

Clinical Trials on Biodex Balane System

Subscribe